Up in smoke? Boton makes pharma bet as vaping dream fades
A new acquisition is taking the e-cigarette maker back to its roots in chemically developed flavors and fragrances Key Takeaways: Vaping products maker Boton will acquire 49% of an active…
3318.HK
Recent Articles
RELATED ARTICLES
-
RLX casts smoke screen with new European acquisition, overseas revenue blip
RLX.US
-
Citic Bank breezes into China’s insular tobacco sector with new investment
601998.SHG
-
Creality’s 3D-printing dream faces first post-IPO test
3388.HK
-
Gogox dumps China dream that failed to deliver
2246.HK
- CXMT IPO tests China’s state-driven chip dream
- Dobot taps Shenzhen market to fund its bet on humanoid robots
- SiliconFlow’s AI ‘token factory’ dream gets $300 million vote of confidence
Discover hidden China stock gems in our weekly newsletter